Inflammatory and alternatively activated macrophages independently induce metaplasia but cooperatively drive pancreatic precancerous lesion growth

Geou-Yarh Liou; Alicia K Fleming Martinez; Heike R Döppler; Ligia I Bastea; Peter Storz

doi:10.1016/j.isci.2023.106820

Inflammatory and alternatively activated macrophages independently induce metaplasia but cooperatively drive pancreatic precancerous lesion growth

iScience. 2023 May 5;26(6):106820. doi: 10.1016/j.isci.2023.106820. eCollection 2023 Jun 16.

Authors

Geou-Yarh Liou^{1

2}, Alicia K Fleming Martinez¹, Heike R Döppler¹, Ligia I Bastea¹, Peter Storz¹

Affiliations

¹ Department of Cancer Biology, Mayo Clinic, Jacksonville, FL 32224, USA.
² Department of Biological Sciences, Center for Cancer Research & Therapeutic Development, Clark Atlanta University, Atlanta, GA 30314, USA.

Abstract

The innate immune system has a key role in pancreatic cancer initiation, but the specific contribution of different macrophage populations is still ill-defined. While inflammatory (M1) macrophages have been shown to drive acinar-to-ductal metaplasia (ADM), a cancer initiating event, alternatively activated (M2) macrophages have been attributed to lesion growth and fibrosis. Here, we determined cytokines and chemokines secreted by both macrophage subtypes. Then, we analyzed their role in ADM initiation and lesion growth, finding that while M1 secrete TNF, CCL5, and IL-6 to drive ADM, M2 induce this dedifferentiation process via CCL2, but the effects are not additive. This is because CCL2 induces ADM by generating ROS and upregulating EGFR signaling, thus using the same mechanism as cytokines from inflammatory macrophages. Therefore, while effects on ADM are not additive between macrophage polarization types, both act synergistically on the growth of low-grade lesions by activating different MAPK pathways.

Keywords: Cancer; Cell biology; Immunology; Molecular biology.